Market Cap 212.31M
Revenue (ttm) 194.06M
Net Income (ttm) 14.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 478.00
Profit Margin 7.39%
Debt to Equity Ratio 0.00
Volume 1,121,000
Avg Vol 1,345,196
Day's Range N/A - N/A
Shares Out 48.36M
Stochastic %K 3%
Beta 2.03
Analysts Strong Sell
Price Target $9.88

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides vi...

Industry: Health Information Services
Sector: Healthcare
Phone: 866 351 5907
Website: lifemd.com
Address:
236 Fifth Avenue, Suite 400, New York, United States
MarioAndretti
MarioAndretti May. 13 at 2:25 AM
$LFMD hope we hit 4 this is undervalued should be at 7-8.
0 · Reply
TaoistTrader
TaoistTrader May. 12 at 9:05 PM
$HIMS $LFMD ‼️⛔️⚠️ danger zone
0 · Reply
30DeltaSpy
30DeltaSpy May. 12 at 2:41 PM
$HIMS $LFMD $NVO NVO has 130% upside potential I am bullish on this one 1️⃣
0 · Reply
Floyd_Mayweather_JR
Floyd_Mayweather_JR May. 12 at 3:43 AM
$HIMS this will end up like $LFMD and $TDOC history doesn’t always repeat but it often rhymes
2 · Reply
Alex1965
Alex1965 May. 11 at 10:51 PM
$LFMD I guess HIMS is going down to the $15 - $17 range again. Maybe that will teach the HIMS’s Trolls to stay on their side of the fence. And a new opportunity for new LT investors.
0 · Reply
Leroy_Jankins
Leroy_Jankins May. 11 at 8:19 PM
$LFMD where’s the latest LifeMD “We are not just a GLP-1 company” talk on Alpha Wolf??
1 · Reply
TaoistTrader
TaoistTrader May. 11 at 8:18 PM
$LFMD danger zone after $HIMS crappy earnings. Below 4 this is down the tubes bye bye
0 · Reply
thejman1
thejman1 May. 9 at 8:48 PM
$LFMD company keeps rolling out new stuff and nothing is profitable. nothing innovative. ceo keeps talking about care is amazing and all the subcribers. this company has so many bad reviews. People sign up. realize it isnt worth it. get hit with some additional hidden fees and never come back. explains all the bad reviews. same thing with worksimpli and rexmd. company has nothing that makes it unique. they just keep diluting share holders to pay employees with created shares. and they accomplish nothing but losses. probably bankrupt in 2 years. and 20 to 30% dilution. this is what is shown year after year.
1 · Reply
Leroy_Jankins
Leroy_Jankins May. 9 at 10:16 AM
$LFMD i wish these guys would just come out and say “GLP-1s were just one peptide and are a $100BN a year opportunity. LifeMD is going to go full steam ahead on incorporating peptides into our treatment plans and will become the de facto source for people to learn about and receive peptide treatment options” Complete game changer. Higher risk but they need to be at the forefront of this generational pivot in treatment options, not playing catchup to HIMS/RO/AMZN
0 · Reply
TaoistTrader
TaoistTrader May. 8 at 11:13 AM
$LFMD seems like it’s recovering. Stays above 4.4 it could be fine; below 4 it’s back to no mans land. I truly believe they are sand bagging for new CFO. It wouldn’t be wise to come out full throttle after his first ER. Set em up for success
1 · Reply
Latest News on LFMD
LifeMD Reports First Quarter 2026 Results

May 6, 2026, 4:05 PM EDT - 6 days ago

LifeMD Reports First Quarter 2026 Results

LFMD


LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mar 9, 2026, 4:05 PM EDT - 2 months ago

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LFMD


LifeMD Reports Third Quarter 2025 Results

Nov 17, 2025, 4:05 PM EST - 6 months ago

LifeMD Reports Third Quarter 2025 Results

LFMD


LifeMD to Participate in the BTIG Digital Health Forum

Nov 10, 2025, 8:00 AM EST - 6 months ago

LifeMD to Participate in the BTIG Digital Health Forum

LFMD


MarioAndretti
MarioAndretti May. 13 at 2:25 AM
$LFMD hope we hit 4 this is undervalued should be at 7-8.
0 · Reply
TaoistTrader
TaoistTrader May. 12 at 9:05 PM
$HIMS $LFMD ‼️⛔️⚠️ danger zone
0 · Reply
30DeltaSpy
30DeltaSpy May. 12 at 2:41 PM
$HIMS $LFMD $NVO NVO has 130% upside potential I am bullish on this one 1️⃣
0 · Reply
Floyd_Mayweather_JR
Floyd_Mayweather_JR May. 12 at 3:43 AM
$HIMS this will end up like $LFMD and $TDOC history doesn’t always repeat but it often rhymes
2 · Reply
Alex1965
Alex1965 May. 11 at 10:51 PM
$LFMD I guess HIMS is going down to the $15 - $17 range again. Maybe that will teach the HIMS’s Trolls to stay on their side of the fence. And a new opportunity for new LT investors.
0 · Reply
Leroy_Jankins
Leroy_Jankins May. 11 at 8:19 PM
$LFMD where’s the latest LifeMD “We are not just a GLP-1 company” talk on Alpha Wolf??
1 · Reply
TaoistTrader
TaoistTrader May. 11 at 8:18 PM
$LFMD danger zone after $HIMS crappy earnings. Below 4 this is down the tubes bye bye
0 · Reply
thejman1
thejman1 May. 9 at 8:48 PM
$LFMD company keeps rolling out new stuff and nothing is profitable. nothing innovative. ceo keeps talking about care is amazing and all the subcribers. this company has so many bad reviews. People sign up. realize it isnt worth it. get hit with some additional hidden fees and never come back. explains all the bad reviews. same thing with worksimpli and rexmd. company has nothing that makes it unique. they just keep diluting share holders to pay employees with created shares. and they accomplish nothing but losses. probably bankrupt in 2 years. and 20 to 30% dilution. this is what is shown year after year.
1 · Reply
Leroy_Jankins
Leroy_Jankins May. 9 at 10:16 AM
$LFMD i wish these guys would just come out and say “GLP-1s were just one peptide and are a $100BN a year opportunity. LifeMD is going to go full steam ahead on incorporating peptides into our treatment plans and will become the de facto source for people to learn about and receive peptide treatment options” Complete game changer. Higher risk but they need to be at the forefront of this generational pivot in treatment options, not playing catchup to HIMS/RO/AMZN
0 · Reply
TaoistTrader
TaoistTrader May. 8 at 11:13 AM
$LFMD seems like it’s recovering. Stays above 4.4 it could be fine; below 4 it’s back to no mans land. I truly believe they are sand bagging for new CFO. It wouldn’t be wise to come out full throttle after his first ER. Set em up for success
1 · Reply
MarioAndretti
MarioAndretti May. 8 at 1:08 AM
$HIMS heading to 8$ in 2-3 years seen this before one lawsuit and back down she goes. I’ve been here since Microsoft launched their IPO. You want to invest in a tested and tried company $LFMD their ya go. And that’s free bitch
2 · Reply
dogfisher
dogfisher May. 7 at 11:16 PM
$LFMD Justin is a COO at best, but definitely not a CEO
0 · Reply
Phil1973
Phil1973 May. 7 at 11:00 PM
$LFMD https://seekingalpha.com/news/4588376-amazon-to-offer-novo-ozempic-pill
0 · Reply
Leroy_Jankins
Leroy_Jankins May. 7 at 5:22 PM
$LFMD if the company has such great upside potential some of the employees would buy but they don’t buy, they only sell. It’s been a pattern of award SBC and then everyone sells. I wish it had as much upside as they want people to believe but if even they believed it they would buy
0 · Reply
ClarissaLove
ClarissaLove May. 7 at 5:05 PM
$HIMS $LFMD Nope. Keep dreaming.
0 · Reply
Alex1965
Alex1965 May. 7 at 4:49 PM
$LFMD I say another $4 to $7 millions in the back half of the year...
0 · Reply
Alex1965
Alex1965 May. 7 at 4:48 PM
$LFMD Just another pump by a pumper, or NOT ?
0 · Reply
Alex1965
Alex1965 May. 7 at 4:05 PM
$LFMD We were stuck under $3 just 2 months ago. The 50DA is $3.92 and the 200DA is $4.97. While the P/S is just 1X. No debt and enough cash and financing to pull this step up in S&M in Q1 to take advantage of the market conditions. Which BTW I hope we do this every year. And then reduce it gradually through out the year. And the Medicare effect post June is NOT included in the guidance. I think we will be fine for the time being. The report to watch is the Q3 next November and the Q4 and YE in march next year. The is no selling anymore into a mixed report that was announced with plenty of time in advance. I believe that my read is just fine...
0 · Reply
Alex1965
Alex1965 May. 7 at 3:46 PM
$LFMD Pop, Pop pop pop for the rebound !!!
0 · Reply
Alex1965
Alex1965 May. 7 at 3:13 PM
$LFMD $6.25 to $6.50 in a month from now..
0 · Reply
Alex1965
Alex1965 May. 7 at 3:12 PM
$LFMD IDK but when I am disappointed with any of my investment I just sell everything and move on. I did so a couple of days ago with a company I owned for over 6 years and bought its peer which seemed a lot better. Why complain and suffer for something I don't believe in any more ?
0 · Reply
Piergiorgiop
Piergiorgiop May. 7 at 2:25 PM
$LFMD What is the explanation for this decline after a positive quarter?
0 · Reply